Stay updated with breaking news from Douglas loe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Monday's analyst upgrades and downgrades - The Globe and Mail theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Cardiol Therapeutics Inc is commercializing its THC-free cannabidiol formulation to treat heart disease proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Proprietary formulation produces ultra-pure pharmaceutical cannabidiol (CBD) without the psychotropic effects of THC for the treatment of inflammatory heart disease Received US FDA approval to commence a Phase II/III COVID-19 trial investigating the cardioprotective properties of CardiolRx Has launched Cortalex through a national agreement with Medical Cannabis by Shoppers to retail it on an exclusive basis across Canada Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease. The Canadian specialty pharmaceutical company has developed a proprietary formula of ultra-pure pharmaceutical cannabidiol (CBD) that does not contain THC - less than 5 parts per million (ppm) - and consequently none of the psychotropic effects of THC.
Dieses Unternehmen löst BioNTech & Pfizer's Impfstoffproblem mit Herzmuskelentzündungen! wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
CareRx To Acquire The LTC Pharmacy Division Of Medical Pharmacies; Shares Pop 9% Stephanie Bedard-Chateauneuf- April 19, 2021, 1:14 PM EDT SHARE ON: CareRx shares jumped more than 9% in early trading on Monday after the company announced that it has signed an agreement to acquire the Long-Term Care Pharmacy Division of Medical Pharmacies Group Limited. This acquisition adds approximatively 36,000 residents served and C$150 million in annual revenue. It is expected to pay off immediately with significant synergies. At closing, CareRx ( CRRX) expects to serve more than 88,000 residents, strengthening the company’s position as the leading provider of senior pharmacies in Canada CareRx President and CEO David Murphy said, “The acquisition of MPGL’s LTC Pharmacy Division is our most transformational acquisition to date and will increase the number of homes and residents we service by approximately 70%. MPGL’s LTC Pharmacy Division has a reputation for service and clinical excellence and, as part of CareRx, will provide strategic benefits that we are confident will further strengthen our service offering to our customers, while enhancing our future growth opportunities. With our proven track record of integrating acquisitions, we expect to generate significant operational synergies that will contribute to a meaningful expansion of our EBITDA margin.”